Cytokinetics

Cytokinetics

Biotechnology Research

South San Francisco, California 27,659 followers

Empowering Muscle Empowering Lives

About us

Cytokinetics is a late-stage biopharmaceutical company focused on discovering, developing and commercializing first-in-class muscle activators and next-in-class muscle inhibitors as potential treatments for debilitating diseases in which muscle performance is compromised and/or declining. As a leader in muscle biology and the mechanics of muscle performance, we are developing small molecule drug candidates specifically engineered to impact muscle function and contractility. Proud to be a San Francisco Business Times Best Place to Work in 2021 and 2022, a Great Place to Work-Certified company in 2022 and a part of Fortune's Best Workplaces in the Bay Area in 2022 and Fortune's Best Workplaces in BioPharma in 2022.

Industry
Biotechnology Research
Company size
201-500 employees
Headquarters
South San Francisco, California
Type
Public Company
Founded
1998
Specialties
Heart Failure, Amyotrophic Lateral Sclerosis, and Hypertrophic Cardiomyopathy

Locations

  • Primary

    350 Oyster Point Blvd

    South San Francisco, California 94080, US

    Get directions

Employees at Cytokinetics

Updates

Similar pages

Browse jobs

Funding

Cytokinetics 11 total rounds

Last Round

Post IPO equity

US$ 550.0M

See more info on crunchbase